SS
DRMA icon

SBI Securities’s Dermata Therapeutics DRMA Stock Holding History

SBI Securities’s Portfolio DRMA Stock Details DRMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130 Hold
101
– – ﹤0.01% 3448
2026
Q1 		$122 Hold
101
– – ﹤0.01% 3367
2025
Q4 		$234 Hold
101
– – ﹤0.01% 3161
2025
Q3 		$507 Hold
101
– – ﹤0.01% 2956
2025
Q2 		$591 Buy
101
+1
+1% +$8 ﹤0.01% 2902
2025
Q1 		$1.08K Hold
100
– – ﹤0.01% 2547
2024
Q4 		$1.35K Buy
+100
New +$1.29K ﹤0.01% 2475

Other funds holding DRMA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.8B AUM 19.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

SBI Securities's DRMA Position: Q2 2026 in Review

SBI Securities held its Dermata Therapeutics (DRMA) position steady in Q2 2026 at 101 shares worth $130. The position accounts for ﹤0.01% of the portfolio, ranked #3448.

SBI Securities first reported a position in DRMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.35K in Q4 2024. 13 funds tracked by Wall St. Rank hold DRMA as of Q2 2026.

  • SBI Securities held 101 shares of Dermata Therapeutics worth $130 as of Q2 2026.
  • SBI Securities left its Dermata Therapeutics share count unchanged in Q2 2026.
  • Dermata Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3448 holding.
  • SBI Securities first reported a position in Dermata Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Dermata Therapeutics position peaked at $1.35K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Dermata Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.